Literature DB >> 25810391

NF-κB regulates PD-1 expression in macrophages.

Alexander P R Bally1, Peiyuan Lu1, Yan Tang2, James W Austin1, Christopher D Scharer1, Rafi Ahmed1, Jeremy M Boss3.   

Abstract

Programmed cell death-1 (PD-1) is responsible for T cell exhaustion during chronic viral infections and is expressed on a variety of immune cells following activation. Despite its importance, the mechanisms that regulate PD-1 in cell types other than CD8 T cells are poorly defined. In this study, the molecular mechanisms for inducing PD-1 expression in CD4 T cells, macrophages, and B cells were explored. In CD4 T cells, PD-1 induction following TCR stimulation required NFAT, as the calcineurin/NFAT pathway inhibitor cyclosporin A was able to block PD-1 induction in a manner similar to that seen in CD8 T cells. In contrast, LPS but not PMA and ionomycin stimulation was able to induce PD-1 expression in macrophages in a manner insensitive to cyclosporin A-mediated inhibition. B cells could use both pathways, although the levels of PD-1 expression were highest with PMA and ionomycin. An NF-κB binding site located upstream of the gene in conserved region C was required for NF-κB-dependent PD-1 gene activation in macrophages. Chromatin immunoprecipitation showed NF-κB p65 binding to this region following stimulation of macrophages with LPS. PD-1 induction was associated with histone modifications characteristic of accessible chromatin; however, in contrast to CD8 T cells, conserved region B in macrophages did not lose CpG methylation upon stimulation and PD-1 expression. The linkage of TLR/NF-κB signaling to the induction of PD-1 suggests the possibility of an opportunistic advantage to microbial infections in manipulating immune inhibitory responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25810391      PMCID: PMC4402259          DOI: 10.4049/jimmunol.1402550

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

Review 2.  Extrinsic and intrinsic control of macrophage inflammatory responses.

Authors:  Heather B Cohen; David M Mosser
Journal:  J Leukoc Biol       Date:  2013-08-20       Impact factor: 4.962

3.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

4.  BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

Authors:  James R Burke; Mark A Pattoli; Kurt R Gregor; Patrick J Brassil; John F MacMaster; Kim W McIntyre; Xiaoxia Yang; Violetta S Iotzova; Wendy Clarke; Joann Strnad; Yuping Qiu; F Christopher Zusi
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

5.  Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.

Authors:  Ying Zhang; Cheng J Ma; Lei Ni; Chun L Zhang; Xiao Y Wu; Uday Kumaraguru; Chuan F Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

6.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

7.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. I. Evidence for two separate Me2+ binding sites with opposing effects on the pore open probability.

Authors:  P Bernardi; P Veronese; V Petronilli
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

8.  Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock.

Authors:  Jon A Hagar; Daniel A Powell; Youssef Aachoui; Robert K Ernst; Edward A Miao
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

9.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection.

Authors:  Peiyuan Lu; Benjamin A Youngblood; James W Austin; Ata Ur Rasheed Mohammed; Royce Butler; Rafi Ahmed; Jeremy M Boss
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

View more
  54 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

2.  Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Authors:  Simone Borgoni; Andrea Iannello; Santina Cutrupi; Paola Allavena; Maurizio D'Incalci; Francesco Novelli; Paola Cappello
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 3.  Transcriptional and epigenetic regulation of PD-1 expression.

Authors:  Zengde Chi; Yan Lu; Yinlong Yang; Bingqing Li; Peiyuan Lu
Journal:  Cell Mol Life Sci       Date:  2021-03-18       Impact factor: 9.261

4.  Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC.

Authors:  Akira Asai; Yusuke Tsuchimoto; Hideko Ohama; Shinya Fukunishi; Yasuhiro Tsuda; Makiko Kobayashi; Kazuhide Higuchi; Fujio Suzuki
Journal:  Oncoimmunology       Date:  2017-03-03       Impact factor: 8.110

5.  Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.

Authors:  Alexander P R Bally; Yan Tang; Joshua T Lee; Benjamin G Barwick; Ryan Martinez; Brian D Evavold; Jeremy M Boss
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

6.  Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.

Authors:  Hashem O Alsaab; Samaresh Sau; Rami M Alzhrani; Vino T Cheriyan; Lisa A Polin; Ulka Vaishampayan; Arun K Rishi; Arun K Iyer
Journal:  Biomaterials       Date:  2018-08-30       Impact factor: 12.479

7.  Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery.

Authors:  Jieke Cui; Qing Li; Mei Luo; Zhaodong Zhong; Shu Zhou; Lin Jiang; Na Shen; Zhe Geng; Hui Cheng; Li Meng; Shujuan Yi; Hui Sun; Feifei Wu; Zunmin Zhu; Ping Zou; Yong You; An-Yuan Guo; Xiaojian Zhu
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

Review 8.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 9.  Genetic and Epigenetic Regulation of PD-1 Expression.

Authors:  Alexander P R Bally; James W Austin; Jeremy M Boss
Journal:  J Immunol       Date:  2016-03-15       Impact factor: 5.422

10.  Mycophenolate Mofetil Protects Septic Mice via the Dual Inhibition of Inflammatory Cytokines and PD-1.

Authors:  Shun-Wei Huang; Hao Chen; Mei-Ling Lu; Jin-Long Wang; Rong-Li Xie; Bing Zhao; Ying Chen; Zhi-Wei Xu; Jian Fei; En-Qiang Mao; Er-Zhen Chen
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.